Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Skeeter Bug who wrote (30172)	1/12/2000 6:45:00 PM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 32384

Skeeter, a lot of things seem to be known by some even though they haven't been announced. Take McCamant's estimate of $100M in sales. I couldn't have come up with that number no matter how hard I'd tried. Not without including the B-cell lymphoma indications. The information was apparently available even though Ligand hasn't been blowing trumpets about it. Not yet anyway. In regard to the rotation away from the Internet issues, I think that's well under way. A lot of people would like to take their massive gains before everyone decides to head for the door. Among them are surely some significant funds. Of major interest will be the next short figure. If it isn't up, then the recent trading pattern cannot have been caused by short sellers manipulating the stock - on some days, there were enough small chunks on upticks followed by large blocks on downticks that it could have been shorting - and if that's so, then the only possible explanation I can see is major accumulation. All speculation; the next few weeks should tell the story well enough. Cheers, Torben